The promise of remote patient monitoring is showing itself in more and more telemedicine use cases, with huge potential for day-to-day wellness, management of chronic conditions and the promotion of ...

Despite substantial advances in guideline-directed medical therapy, recurrent hospitalization remains a persistent challenge in the management of congestive heart failure (CHF). Fluid overload is ...

Counterpart Health, Inc., a subsidiary of Clover Health, released research indicating that its AI-powered platform, Counterpart Assistant (CA), significantly improves the management of congestive ...

Approximately 6.7 million Americans over the age of 20 currently live with heart failure, with this number projected to rise to 8.5 million by 2030. The lifetime risk of developing heart failure has ...

Key opinion leaders provide an overview of the treatment gaps in the management of heart failure. John McMurray, MBChB: Although I said that we have had many successes in the treatment of heart ...

An intervention of variable intensity for congestive heart failure showed some improvements but no survival effect, suggesting a tradeoff between intervention cost and intensity and survival benefit.

Cutting-edge science and stimulating discussions in heart failure management are in store at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC). Heart Failure is the ...

Objective: To provide an overview of heart failure with preserved ejection fraction (HFPEF), as well as its pathophysiology, diagnosis, and clinical evidence regarding its pharmacologic management.

As a cardiologist, I’ve seen first-hand the devastating toll heart failure takes on individuals and their loved ones. This significant and growing public health issue affects millions worldwide and ...